Table 4 Change in total symptom score.
| Total symptom score | ||||
|---|---|---|---|---|
| Visits | NAAGA (n = 11*) | LEVO (n = 12*) | ||
| Mean (SD) | Median (quartiles) | Mean (SD) | Median (quartiles) | |
| D0 | 5.8 (0.9) | 6.0 (5.0; 6.0) | 5.8 (1.3) | 5.5 (5.0; 7.0) |
| D7 | 3.5 (2.0) | 3.0 (2.0; 4.0) | 4.1 (1.9) | 4.5 (3.0; 6.0) |
| D28 | 2.7 (1.3) | 2.0 (2.0; 4.0) | 3.7 (2.2) | 3.0 (2.0; 6.0) |
| Treatment effect†; 95% CI | p value† | |||
|---|---|---|---|---|
| At D7 | −0.6 (−2.2; 1.0) | 0.445 | ||
| At D28 | −1.0 (−2.5; 0.4) | 0.160 | ||
| At both visits | −0.8 (−2.1; 0.5) | 0.213 |
*Naaga group: day 0 n = 11, day 7 n = 11 and day 28 n = 10. Levo group: day 0 n = 12; day 7 n = 12 and day 28 n = 11; †difference in least‐squares means and Student t test p value.